Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
PLoS Negl Trop Dis ; 15(8): e0009575, 2021 08.
Article in English | MEDLINE | ID: mdl-34351896

ABSTRACT

Since the 2015 to 2016 outbreak in America, Zika virus (ZIKV) infected almost 900,000 patients. This international public health emergency was mainly associated with a significant increase in the number of newborns with congenital microcephaly and abnormal neurologic development, known as congenital Zika syndrome (CZS). Furthermore, Guillain-Barré syndrome (GBS), a neuroimmune disorder of adults, has also been associated with ZIKV infection. Currently, the number of ZIKV-infected patients has decreased, and most of the cases recently reported present as a mild and self-limiting febrile illness. However, based on its natural history of a typical example of reemerging pathogen and the lack of specific therapeutic options against ZIKV infection, new outbreaks can occur worldwide, demanding the attention of researchers and government authorities. Here, we discuss the clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations. Several studies have confirmed the tropism of ZIKV for neural progenitor stem cells by demonstrating the presence of ZIKV in the central nervous system (CNS) during fetal development, eliciting a deleterious inflammatory response that compromises neurogenesis and brain formation. Of note, while the neuropathology of CZS can be due to a direct viral neuropathic effect, adults may develop neuroimmune manifestations such as GBS due to poorly understood mechanisms. Antiganglioside autoantibodies have been detected in multiple patients with ZIKV infection-associated GBS, suggesting a molecular mimicry. However, further additional immunopathological mechanisms remain to be uncovered, paving the way for new therapeutic strategies.


Subject(s)
Brain/embryology , Guillain-Barre Syndrome/virology , Microcephaly/virology , Zika Virus Infection/pathology , Zika Virus/pathogenicity , Animals , Brain/virology , Female , Guillain-Barre Syndrome/etiology , Humans , Mice , Neural Stem Cells/virology , Pregnancy , Pregnancy Complications, Infectious , Zika Virus Infection/virology
2.
Nat Commun ; 9(1): 475, 2018 02 02.
Article in English | MEDLINE | ID: mdl-29396410

ABSTRACT

Congenital Zika syndrome (CZS) causes early brain development impairment by affecting neural progenitor cells (NPCs). Here, we analyze NPCs from three pairs of dizygotic twins discordant for CZS. We compare by RNA-Seq the NPCs derived from CZS-affected and CZS-unaffected twins. Prior to Zika virus (ZIKV) infection the NPCs from CZS babies show a significantly different gene expression signature of mTOR and Wnt pathway regulators, key to a neurodevelopmental program. Following ZIKV in vitro infection, cells from affected individuals have significantly higher ZIKV replication and reduced cell growth. Whole-exome analysis in 18 affected CZS babies as compared to 5 unaffected twins and 609 controls excludes a monogenic model to explain resistance or increased susceptibility to CZS development. Overall, our results indicate that CZS is not a stochastic event and depends on NPC intrinsic susceptibility, possibly related to oligogenic and/or epigenetic mechanisms.


Subject(s)
Brain/embryology , Gene Expression , Neural Stem Cells/metabolism , Twins, Dizygotic , Zika Virus Infection/congenital , Brain/metabolism , Brain/virology , Brazil , Case-Control Studies , Female , Genetic Predisposition to Disease , High-Throughput Nucleotide Sequencing , Humans , Induced Pluripotent Stem Cells , Infant , Infant, Newborn , Male , Neural Stem Cells/virology , Sequence Analysis, RNA , TOR Serine-Threonine Kinases/genetics , Wnt Signaling Pathway/genetics , Zika Virus Infection/genetics , Zika Virus Infection/virology
3.
Expert Opin Biol Ther ; 17(8): 945-959, 2017 08.
Article in English | MEDLINE | ID: mdl-28604109

ABSTRACT

INTRODUCTION: Breast cancer is the most common cancer in women all over the world. Furthermore, up to one third of breast tumors develop metastases that are resistant to standard therapies. Gene therapeutic strategies have been developed in order to specifically target cancer cells either directly or through the stimulation of antitumor immunity. Areas covered: This review describes the therapeutic strategies that are currently under development to treat this disease using engineered viral vectors including: adenovirus, adeno-associated virus, lentivirus, poxvirus, reovirus, baculovirus, herpesvirus and oncolytic viruses. Advantages and disadvantages of these multiple gene therapy platforms are discussed in detail. Expert opinion: Metastatic breast cancer is a perfect candidate for gene therapy approaches due to the presence of several tumor antigens and the aberrant expression of many molecular pathways. Oncolytic vectors are able to attack tumor cells while sparing normal cells and their activity is often enhanced by the administration of chemotherapy. However, more efforts are needed in order to reduce toxicity and to achieve better transduction efficiency. Improved preclinical models and a more critical patient selection for clinical trials, along with advances in gene therapy regulations, will surely facilitate the evolution of gene therapy for the treatment of metastatic breast cancer.


Subject(s)
Breast Neoplasms/therapy , Oncolytic Virotherapy , Adenoviridae/genetics , Female , Genetic Vectors/genetics , Genetic Vectors/metabolism , Humans , Lentivirus/genetics , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/virology , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Neural Stem Cells/virology , Oncolytic Viruses/genetics , Poxviridae/genetics
4.
Cell Microbiol ; 19(6)2017 06.
Article in English | MEDLINE | ID: mdl-28370966

ABSTRACT

Starting with the outbreak in Brazil, Zika virus (ZIKV) infection has been correlated with severe syndromes such as congenital Zika syndrome and Guillain-Barré syndrome. Here, we review the status of Zika virus pathogenesis in the central nervous system (CNS). One of the main concerns about ZIKV exposure during pregnancy is abnormal brain development, which results in microcephaly in newborns. Recent advances in in vitro research show that ZIKV can infect and obliterate cells from the CNS, such as progenitors, neurons, and glial cells. Neural progenitor cells seem to be the main target of the virus, with infection leading to less cell migration, neurogenesis impairment, cell death and, consequently, microcephaly in newborns. The downsizing of the brain can be directly associated with defective development of the cortical layer. In addition, in vivo investigations in mice reveal that ZIKV can cross the placenta and migrate to fetuses, but with a significant neurotropism, which results in brain damage for the pups. Another finding shows that hydrocephaly is an additional consequence of ZIKV infection, being detected during embryonic and fetal development in mouse, as well as after birth in humans. In spite of the advances in ZIKV research in the last year, the mechanisms underlying ZIKV infection in the CNS require further investigation particularly as there are currently no treatments or vaccines against ZIKV infection.


Subject(s)
Brain/embryology , Hydrocephalus/virology , Microcephaly/virology , Zika Virus Infection/pathology , Zika Virus/pathogenicity , Animals , Brain/virology , Cell Movement/physiology , Female , Humans , Mice , Neural Stem Cells/virology , Pregnancy , Pregnancy Complications, Infectious , Zika Virus Infection/virology
5.
Biochem Biophys Res Commun ; 492(4): 603-607, 2017 10 28.
Article in English | MEDLINE | ID: mdl-28108286

ABSTRACT

The recent outbreak of ZIKV in Brazil called the attention of the world because the effects of viral infection in the brain under development in fetuses. Consequences of vertical infection comprise brain malformation, especially microcephaly, eye and musculoskeletal abnormalities, among others. In adults, outcomes of infection include meningoencephalitis and Guillain-Barré Syndrome. Recent data specific suggest that neural progenitor cells are the main targets of ZIKV infection, causing massive cellular death and impairment in the neurogenesis process. Here we review the fetal and adult brain damage after ZIKV exposure, exploring models to study the mechanisms underlying the pathways related to microcephaly and cell death.


Subject(s)
Brain/virology , Encephalitis, Viral/virology , Neural Stem Cells/virology , Pregnancy Complications, Infectious/virology , Zika Virus Infection/virology , Zika Virus/physiology , Animals , Apoptosis , Brain/pathology , Encephalitis, Viral/pathology , Female , Humans , Neural Stem Cells/pathology , Pregnancy , Pregnancy Complications, Infectious/pathology , Zika Virus Infection/pathology
6.
Sci Rep ; 6: 39775, 2016 12 23.
Article in English | MEDLINE | ID: mdl-28008958

ABSTRACT

Zika virus (ZIKV) infection has been associated with severe complications both in the developing and adult nervous system. To investigate the deleterious effects of ZIKV infection, we used human neural progenitor cells (NPC), derived from induced pluripotent stem cells (iPSC). We found that NPC are highly susceptible to ZIKV and the infection results in cell death. ZIKV infection led to a marked reduction in cell proliferation, ultrastructural alterations and induction of autophagy. Induction of apoptosis of Sox2+ cells was demonstrated by activation of caspases 3/7, 8 and 9, and by ultrastructural and flow cytometry analyses. ZIKV-induced death of Sox2+ cells was prevented by incubation with the pan-caspase inhibitor, Z-VAD-FMK. By confocal microscopy analysis we found an increased number of cells with supernumerary centrosomes. Live imaging showed a significant increase in mitosis abnormalities, including multipolar spindle, chromosome laggards, micronuclei and death of progeny after cell division. FISH analysis for chromosomes 12 and 17 showed increased frequency of aneuploidy, such as monosomy, trisomy and polyploidy. Our study reinforces the link between ZIKV and abnormalities in the developing human brain, including microcephaly.


Subject(s)
Apoptosis , Mitosis , Neural Stem Cells/metabolism , Neural Stem Cells/virology , Zika Virus Infection/metabolism , Zika Virus/metabolism , Cells, Cultured , Humans , Neural Stem Cells/pathology , Zika Virus Infection/pathology
8.
Nature ; 534(7606): 267-71, 2016 06 09.
Article in English | MEDLINE | ID: mdl-27279226

ABSTRACT

Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinel Rhesus monkeys. Until the twentieth century, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored by Aedes aegypti mosquitoes, ZIKV caused the first noteworthy epidemic on the Yap Island in Micronesia. Patients experienced fever, skin rash, arthralgia and conjunctivitis. From 2013 to 2015, the Asian lineage of the virus caused further massive outbreaks in New Caledonia and French Polynesia. In 2013, ZIKV reached Brazil, later spreading to other countries in South and Central America. In Brazil, the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barré syndrome. Despite clinical evidence, direct experimental proof showing that the Brazilian ZIKV (ZIKV(BR)) strain causes birth defects remains absent. Here we demonstrate that ZIKV(BR) infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice. Moreover, the virus infects human cortical progenitor cells, leading to an increase in cell death. We also report that the infection of human brain organoids results in a reduction of proliferative zones and disrupted cortical layers. These results indicate that ZIKV(BR) crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment. Our data reinforce the growing body of evidence linking the ZIKV(BR) outbreak to the alarming number of cases of congenital brain malformations. Our model can be used to determine the efficiency of therapeutic approaches to counteracting the harmful impact of ZIKV(BR) in human neurodevelopment.


Subject(s)
Disease Models, Animal , Microcephaly/virology , Zika Virus/pathogenicity , Animals , Apoptosis , Autophagy , Brain/pathology , Brain/virology , Brazil/epidemiology , Cell Proliferation , Female , Fetal Growth Retardation/pathology , Fetal Growth Retardation/virology , Fetus/virology , Mice , Microcephaly/epidemiology , Microcephaly/etiology , Microcephaly/pathology , Neural Stem Cells/pathology , Neural Stem Cells/virology , Organoids/pathology , Organoids/virology , Placenta/virology , Pregnancy , Zika Virus Infection/complications , Zika Virus Infection/epidemiology , Zika Virus Infection/pathology , Zika Virus Infection/virology
11.
Science ; 352(6287): 816-8, 2016 May 13.
Article in English | MEDLINE | ID: mdl-27064148

ABSTRACT

Since the emergence of Zika virus (ZIKV), reports of microcephaly have increased considerably in Brazil; however, causality between the viral epidemic and malformations in fetal brains needs further confirmation. We examined the effects of ZIKV infection in human neural stem cells growing as neurospheres and brain organoids. Using immunocytochemistry and electron microscopy, we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development.


Subject(s)
Brain/abnormalities , Brain/virology , Microcephaly/virology , Neural Stem Cells/virology , Neurogenesis , Zika Virus Infection/complications , Zika Virus/pathogenicity , Brazil , Cell Death , Cells, Cultured , Humans , Microcephaly/pathology , Neural Stem Cells/pathology , Organoids/abnormalities , Organoids/virology , Zika Virus Infection/pathology
SELECTION OF CITATIONS
SEARCH DETAIL